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Abstract
Ataxin-3, the disease protein in the neurodegenerative disorder Spinocerebellar Ataxia Type 3 or Machado Joseph disease, is
a cysteine protease implicated in the ubiquitin proteasome pathway. It contains multiple ubiquitin binding sites through
which it anchors polyubiquitin chains of different linkages that are then cleaved by the N-terminal catalytic (Josephin)
domain. The properties of the ubiquitin interacting motifs (UIMs) in the C-terminus of ataxin-3 are well established. Very
little is known, however, about how two recently identified ubiquitin-binding sites in the Josephin domain contribute to
ubiquitin chain binding and cleavage. In the current study, we sought to define the specific contribution of the Josephin
domain to the catalytic properties of ataxin-3 and assess how the topology and affinity of these binding sites modulate
ataxin-3 activity. Using NMR we modeled the structure of diUb/Josephin complexes and showed that linkage preferences
are imposed by the topology of the two binding sites. Enzymatic studies further helped us to determine a precise hierarchy
between the sites. We establish that the structure of Josephin dictates specificity for K48-linked chains. Site 1, which is close
to the active site, is indispensable for cleavage. Our studies open the way to understand better the cellular function of
ataxin-3 and its link to pathology.
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Introduction
Parsimony in nature reveals itself in many ways. A particularly
elegant biological example is the capacity to regulate divergent
cellular pathways through the versatile properties of a single
modifier protein. An excellent example of a multiple-function
adaptor is ubiquitin (Ub), a small protein implicated in diverse
cellular processes and pathways including transcription, protein
degradation, cell cycle progression, viral infection, and immune
response [1]. Ub represents a large molecular tag added
posttranslationally to protein substrates, either as a single Ub
molecule or as a polyUb chain in which Ub molecules are linked to
one another through any of seven Ub lysine residues. PolyUb chains
of different linkage type play distinct biological roles [2]. The best
studied polyUb chain linkage, the K48-linkage, targets proteins for
degradation by the proteasome [3–5], whereas K63-linked polyUb
chains seem to serve a non-degradative role in transcription
activation and DNA damage [6,7]. Other chain linkages have also
been identified, including branched and mixed-linkage chains,
although their function has not been clarified [8–10].
Understanding how polyUb chains are recognized is an
important, yet still poorly defined issue. It has been suggested
that specificity is achieved by Ub chains interacting with multiple-
domain proteins that contain different Ub binding motifs. One
such protein is ataxin-3, a protein implicated in protein quality
control pathways and transcriptional regulation [11]. Expansion of
a polyglutamine (polyQ) tract in ataxin-3 causes the dominantly
inherited neurodegenerative disease, Spinocerebellar Ataxia Type
3 (SCA3) or Machado-Joseph Disease (MJD). As a member of the
MJD family of deubiquitinating enzymes (DUBs), ataxin-3
preferentially cleaves polyUb chains of four or more Ub subunits
[12,13]. K48-, K63-linked and mixed-linkage chains bind ataxin-
3, but cleavage in vitro occurs preferentially for K63- and K48/
K63-mixed linkage polyUb chains [14]. Ataxin-3 contains a
catalytic N-terminal globular domain (the Josephin domain) with a
cysteine protease fold, and a mostly unstructured C-terminal
region that contains the polyQ tract and two or three Ub
interacting motifs (UIMs), depending on the protein splice isoform
[15]. In pull-down assays and surface plasmon resonance binding
studies, the UIMs mediate Ub chain binding [14,16]. We recently
identified two additional Ub binding surfaces, both in the Josephin
domain [17]. One, previously predicted on the basis of structural
considerations, is close to the active site (site 1); the second Ub-
binding site (site 2) coincides with the interaction surface of the
Ub-like (Ubl) domain of hHR23B [18]. While the UIMs are
clearly important in determining the cleavage specificity of the full-
length protein, very little is understood about the role of the
Josephin binding sites in chain specificity or cleavage. The
potential importance of the two Josephin binding sites is suggested
by their close proximity to the enzyme active site.
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e12430Here, we have investigated the structural constraints imposed by
these two Ub-binding sites and their preferences in polyUb
binding and in selecting the exact branching of Ub chains for
cleavage. We compare the properties of Josephin and full-length
ataxin-3 to cleave different polyUb chains (i.e. with K48, K63 or
mixed linkages) and relate them to the binding and enzymatic
properties of the domain. We observe a clear hierarchy between
the two sites, which is dictated by their structural features and
topological relationship. We also rationalize some of our results in
terms of the structural constraints imposed by the Ub chains.
Results
Ub-binding sites 1 and 2 are not equally important for Ub
chain cleavage by the isolated Josephin domain
To examine the importance of Ub-binding sites 1 and 2 to the
ability of ataxin-3 to cleave poly-Ub chains independently from
the C-terminal UIMs, we carried out enzymatic Ub cleavage
studies using the isolated Josephin domain (amino acids 1–182).
We followed established protocols [14,18]. In parallel we
examined the cleavage properties of wild-type Josephin versus
two mutants (Jos_I77KQ78K and Jos_W87K) that have been
shown to individually abolish binding to site 1 or site 2,
respectively [17] (Fig. 1A). Jos_I77KQ78K mutates two exposed
residues that are close to the active site and are in the interface
with the Ub molecule which binds in site 1. Jos_W87K mutates an
exposed hydrophobic tryptophan found to be essential for binding
both Ub and the Ubl of hHR23B to site 2 [18].
Our results show that Ub-binding site 1 is necessary for the
Josephin domain to cleave K63-linked hexa and K48-linked
pentaUb chains, as well as mixed-linkage chains (Fig. 1B,C,D).
In contrast, site 2 shows a more nuanced involvement in Ub
cleavage by the Josephin domain: site 2 is dispensable for cleavage
of K63-linked chains (Fig. 1B), but mutating site 2 does lead to a
reduction in cleavage of K48-linked and mixed-linkage polyUb
chains (Fig. 1C,D).
These data indicate that site 1 is critically involved in any DUB
activity of the Josephin domain, and suggest an involvement of site
2 in specific linkage recognition or preference by the Josephin
domain.
Ub-binding site 1 is also necessary for full-length ataxin-3
to cleave Ub chains
We next compared our results for the isolated Josephin domain
with those obtained for full-length, non-expanded (Q22) ataxin-3.
Independent of the Jos_I77KQ78K and Jos_W87K mutants
tested above, we generated I77AQ78A and W87A mutants in full-
length ataxin-3. Replacing the bulky hydrophobic residues in sites
1 and 2 with a smaller hydrophobic residue rather than a charged
residue represents a milder mutation. Even so, we obtained results
similar to those observed with the isolated Josephin domain: site 1
proved to be essential for the ability of full-length ataxin-3 to
cleave K63-linked or K48-linked chains (Fig. 2). In contrast, site 2
mutations did not alter the ability of full-length ataxin-3 to cleave
K63-linked chains but did impair cleavage of K48-linked chains.
Together, these results confirm the crucial importance of site 1
in cleaving all Ub chains and a role of site 2 in conferring linkage
preference to ataxin-3.
The isolated Josephin domain has clear preference for
polyUb linkage and length
To gather structural perspective into the role of sites 1 and 2 in
Ub chain cleavage by the isolated Josephin domain, we first tested
whether the Josephin enzymatic activity presents any preference
towards polyUb chains of different lengths and/or linkage. We
first incubated Josephin with either K48-linked or K63-linked
diUb chains. We observed virtually no change in diUb levels or
Figure 1. Relevance of Ub-binding sites 1 and 2 to polyUb chain cleavage by the Josephin domain. A) Josephin structure (1yzb). The
side chains of the mutated residues and of the catalytic triad are indicated in yellow and cyan, respectively. Arrows denote the positions of the two
Ub binding sites. B–D) GST-tagged, isolated Josephin domain samples of wild-type ataxin-3 (ataxin-3(1-182)-WT), mutated in Ub-binding site 1
(ataxin-3(1-182)-I77K-Q78K), or mutated in Ub-binding site 2 (ataxin-3(1-182)-W87K) were incubated with the following Ub chains: B) K63-linked hexa-
Ub (K63-Ub6), C) K48-linked penta-Ub (K48-Ub5), or D) mixed-linkage tetra-Ub (K48-K63-K48-Ub4). Fractions were collected at the indicated times,
electrophoresed on SDS-PAGE gels, and probed as indicated. HMW: high molecular weight Ub chain species that are thought to be dimers and
trimers of the respective chains (14). Graphs below each blot represent semi-quantification of data from three independently run experiments. Shown
are means +/2 standard deviation. Asterisks: P,0.05 (*) or P,0.01 (**) when comparing reaction products from WT ataxin-3 to site-1 or site-2
mutated ataxin-3.
doi:10.1371/journal.pone.0012430.g001
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Fig. 3A, B). The same behavior was observed for full-length
ataxin-3 (data not shown). As a control, we verified that these diUb
chains are cleavable by an unrelated DUB, USP28 [19]. In the
presence of USP28, both K48- and K63-linked diUb chains were
cleaved quickly and efficiently (Fig. 3C). These data indicate that
diUb chains, whether K63- or K48-linked, are poor Josephin
domain and ataxin-3 substrates.
To clarify linkage preferences of the Josephin domain in the
absence of the C-terminal region of ataxin-3, we incubated
isolated Josephin with equal amounts of K48-linked or K63-linked
pentaUb chains (Fig. 3D). The isolated Josephin domain shows
preference for K48 linkages compared to K63-linked chains,
suggesting that the UIMs of ataxin-3 confer a protective effect
toward K48-linked chains.
Finally, we systematically compared Josephin-mediated cleav-
age of K48-linked polyUb chains of increasing length. Longer
chains are cleaved more efficiently than shorter ones, though in
general the first cleavage at any length seems to be more efficient
than successive ones (Fig. 3E).
Isolated Josephin binds both K48- and K63-diUb chains
but with different stoichiometry
To explain the above findings mechanistically, we sought to
obtain a better structural description of the possible complexes
involved. We used nuclear magnetic resonance (NMR) to study
the effects of titrating the isolated Josephin domain with K48- or
K63-linked diUb chains and to collect distance restraints which
could be translated into structural models. A C14A mutant was
used to be sure that no enzymatic cleavage could occur. We
observed similar chemical shift perturbation (CSP) effects for both
diUb linkages (Fig. 4A,B). Diagnostic CSP effects were those
observed for the amide resonances of residues 27, 28, 86 and 87
which are in site 2, and of residues 16, 76, 77, 78, 122 and 133
which are in site 1 [18]. A small number of resonances
disappeared or broadened significantly during the titration,
indicating an intermediate exchange rate. Among these are 116
and 136 in site 1 (close to the catalytic triad) and 35, 36, and 38 in
binding site 2.
We conclude that both Ub binding sites are populated during
the titrations in agreement with what observed for monoUb [18].
Since, however, the two sites could be in principle occupied by Ub
subunits from different polyUb chains, we clarified the stoichiom-
etries by estimating the correlation times of the complexes by
NMR. This is a very sensitive parameter that reflects directly the
molecular weight of the species in solution. By reporting the
correlation times as a function of different Ub:Josephin molar
ratios, we observed that the complex with K48-linked diUb has
always shorter values which tend to reach a plateau, albeit at high
diUb:Josephin molar ratios (Fig. 4C). Close to plateau, the degree
Figure 2. Relevance of Ub-binding sites 1 and 2 to polyUb chain cleavage by full-length ataxin-3. Full-length, untagged ataxin-3 protein
samples that were wild type (ataxin-3(Q22)-WT), mutated in Ub-binding site 1 (ataxin-3(Q22)-I77A-Q78A), mutated in Ub-binding site 2 (ataxin-
3(Q22)-W87A), or mutated in both sites (ataxin-3(Q22)-I77A-Q78A-W87A), were incubated with the following polyUb chains: A) K63-linked hexa-Ub
(K63-Ub6), or B) K48-linked penta-Ub (K48-Ub5). Fractions were collected at the indicated times, electrophoresed on SDS-PAGE gels, and probed as
indicated. Q22 denotes 22 glutamine residues in the polyQ region of ataxin-3. Lower panel for each blot represents semi-quantification of data from
at least three independent experiments. Means +/2 SD. Asterisks: P,0.05 (*) or P,0.01 (**) when comparing reaction products from WT ataxin-3 to
ataxin-3 mutated at site 1, site 2 or both sites 1 and 2.
doi:10.1371/journal.pone.0012430.g002
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[18] is ca. 85%. Under these conditions, the observed correlation
time corresponds to a protein of 31–34 kDa, in excellent
agreement with the molecular weight expected for a 1:1 complex
of Josephin with diUb (35 kDa). The complex with K63-linked
diUb is instead always comparatively longer, and the curve does
not seem to reach a plateau.
These results indicate that Josephin dictates preferential binding
properties for different Ub linkages.
Geometric features of Ub binding sites on Josephin
determine binding specificity
To rationalize these observations, we translated the distance
information into molecular models using the biomolecular docking
program, HADDOCK [20,21]. We performed three docking runs
based on the NMR CSP data. In the first run, we imposed a K48-
diUb linkage in combination with the ambiguous interaction
restraints (AIRs) defined from the CSP data. This resulted in two
ensembles of solutions with similar scores (Fig. 5A). Site 1 (or
proximal) Ub shares the same orientation in all solutions, suggesting
that this site is overall better defined. Upon binding, the hairpin
bends on one side to allow space for the Ub linkage and wraps
around the surface of proximal Ub (i.e. the Ub in site 1 which has
the C-terminus free) which contains the b-sheet. The bending is
much more pronounced than in free Josephin [18], supporting the
hypothesis that this secondary structure element helps determine
bindingspecificity.Twocontiguousbindingsurfacesseeminstead to
be equally compatible with the experimental restraints for Ub
binding to site 2 (distal). One surface is similar to that observed in
the Josephin/mono-Ub complex [17]; the other is formed by
residues in the b1/b2a n da/b3 loops. In both clusters, the aromatic
Josephin side-chains of Y27, F28 and W87 contribute to the
interface. Strikingly, both clusters contain solutions with the C-
terminus of site 1 Ub at close proximity to the Josephin active site,
eventhough noexplicit distance restraintsweredefinedto positiona
Ub close to the active site of Josephin. Comparison of the model of
the K48-linked diUb/Josephin complex with other diUb structures
shows that, to bind both sites, the diUb chain needs to have an
extended linker, adopting a conformation much more open than
that observed for the K48-linked diUb complex with the UBA
domain of HHR23A [22]. K48-linked polyUb chains are known to
exist in solution as a fast dynamic equilibrium between open and
closed conformations [23,24] (Fig. 5B). The closed conformation is
predominant at neutral pH and in the absence of binding partners.
Other diUb complexes do not, however, show the open
conformation necessary to accommodate Josephin.
Figure 3. Cleavage of diUb chains by ataxin-3. A) Isolated Josephin domain species were incubated with K48-linked diUb chains (K48-Ub2) for
the indicated times. Left and right panels are representative of independent trials with little or no detectable DUB activity, respectively. B) Isolated
Josephin domain species were incubated with K63-linked diUb chains (K63-Ub2) for the indicated periods of time. C) GST-tagged USP28 was
incubated with K48-linked or K63-linked diUb chains for the indicated times. D) Equal amounts of penta-Ub K48 or K63-linked chains (K48-Ub5; K63-
Ub5) were incubated with the isolated Josephin domain. Fractions were collected at the indicated times. Lower panel: Quantification of data from the
left panel and other similar experiments (N=3). Shown are means +/2 SD. E) Equal amounts of K48-linked di-, tri-, tetra-, or pentaUb chains were
incubated with the isolated Josephin domain, and fractions were collected at the indicated time points.
doi:10.1371/journal.pone.0012430.g003
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this time imposing a K63 Ub linkage (Fig. 5C). The solutions
were more scattered and no biologically meaningful structures
could be obtained (i.e. none having the Ub C-terminus close to the
catalytic center). Even in the best case (cluster 2), the C-terminus of
site 1 Ub is close only to H119 but not to C14 or N134. To
investigate if this could be an artifact of our docking procedure we
repeated the calculations with an additional distance restraint to
position the C-terminus of the site 1 Ub into the Josephin active
site. No solution was found to satisfy this restraint (data not shown)
indicating that the two subunits of a K63-linked diUb cannot be
accommodated simultaneously in both Josephin sites.
Finally, we performed a run in which the linkage preference was
left ambiguous by defining a linkage restraint including both K48
and K63. Although in principle both linkage types were obtained
at the rigid-body docking stage, the only selected solutions for the
subsequent semi-flexible refinement correspond to the K48
linkage.
These results indicate that the relative position of the Ub
binding sites on Josephin dictate different binding specificities. The
structure of K63-linked diUb is incompatible with the geometric
requirements imposed by the relative position of the two Josephin
binding sites and that only K48-linkage diUb is able to occupy
both Ub-binding sites of Josephin simultaneously.
hHR23A influences the ability of Josephin domain to
cleave polyUb chains
We tested whether the presence of hHR23A has any effect on
ataxin-3 cleavage of polyUb chains. Ataxin-3 is known to interact in
cells and in vitro with the Ubl domain of hHR23A [18,25,26]. This
interaction is centered on residue W87 of ataxin-3, which is also the
critical residue for Ub binding by site 2 [17]. Consistent with this,
HHR23B Ubl was shown to compete monoUb in vitro [18].
The ability of ataxin-3 to cleave polyUb chains is not visibly
affected by the presence of either full-length hHR23A or its
isolated Ubl domain (Figs. 6A and C). However, full-length
hHR23A does reduce the ability of the isolated Josephin domain
to cleave polyUb chains (Figs. 6B and C, block arrows). In
contrast, the isolated Ubl domain of hHR23A does not affect
cleavage by the isolated Josephin domain.
Together, these data argue against a significant impact of
hHR23A/ataxin-3 interaction on the ability of full length ataxin-3
to cleave chains in this specific setup. This becomes particularly
evident when considering that the Ubl domain of hHR23A, which
interacts with ataxin-3, does not have a detectable effect on Ub
cleavage.
Discussion
We previously showed that full-length ataxin-3 binds both K48-
and K63-linked Ub chains, yet preferentially cleaves K63 linkages
in a manner dependent on the UIMs present in the C-terminus of
ataxin-3 [14]. More recently we showed that the amino-terminal
catalytic Josephin domain also contains two distinct Ub binding
sites in addition to the 2-3 UIMs contained in the C-terminus [17].
Central questions directly following from these previous findings
are therefore: What is the specific role of Josephin in cleavage?
And what is the relationship and mutual influence of the multiple
Ub binding sites?
Here, we addressed these questions by dissecting the relative
importance of the Ub binding sites by comparing the behaviour of
the isolated Josephin with that of the full-length protein. In
addition to being important for the non-pathologic functions of the
protein, Josephin has been shown to determine the aggregation
properties of non-expanded ataxin-3 in vitro [27–29], although
still little is known about its role in pathogenesis. Isolated Josephin
species could be generated by alternative splicing or proteolysis.
Cleavage products of expanded ataxin-3 have been reported in
cell, fruit fly and mouse models of SCA3 and in SCA3 disease
brains [30–33], but most of the described fragments are C-
terminal portions of ataxin-3 containing the polyQ domain. N-
terminal cleavage products that include the catalytic triad would
have the capacity to act as a functional DUB whose properties and
Figure 4. NMR titrations and models of Josephin/Ub complex-
es. A) and B) CSPs (Dd) as a function of the amino acid sequences for
the titration of the
15N labelled Josephin with unlabelled K48 (upper
panel) and K63 (lower panel) diUb chains ([Josephin]/[diUb] 1/3).
Asterisks denote residues whose resonances are attenuated upon
binding. C) Comparison of the correlation times measured during
titration of
15N labeled Josephin with K48- and K63-linked diUb chains.
doi:10.1371/journal.pone.0012430.g004
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length ataxin-3. Thus, N-terminal Josephin domain fragments
potentially could influence SCA3 pathogenesis by affecting the
balance in Ub species in patients [34]. Whether this indeed
contributes to SCA3 disease pathogenesis is currently unknown
and certainly deserves future attention.
Independently from a role in pathogenesis, a comparison
between full-length ataxin-3 and isolated Josephin can help us to
understand the relative influence of different and distal regions of
the protein both on its normal function and on disease
pathogenesis. Through a combined use of rationally designed
mutations of the Josephin domain and a detailed comparison of
the enzymatic properties of the domain with those of full-length
ataxin-3, we confirm that, in the absence of other competitors, Ub
chains are able to bind both Ub binding sites of Josephin. The
structure of Josephin does, however, dictate the stoichiometry of
binding and therefore preferentiality for diUb linkages: the two
subunits of K48-linked diUb can populate both sites simulta-
neously whereas K63-linked diUb chains cannot.
The importance for enzymatic activity of the two binding sites
differs greatly. Site 1, which is contiguous to the active site, is
necessary for cleavage as mutations of critical residues in this site to
either lysine or alanine abolish cleavage both by the isolated
Josephin domain and by full-length ataxin-3. Its role must
Figure 5. Modelling of diUb complexes with Josephin. A) Structural superposition of representative models of the Josephin complexes with
K48- (left) and K63-linked (right) diUb. The structures are superposed on Josephin backbone atoms to enhance the similarities/differences of the Ub
relative positions. The C-terminus (residue G76) of the Ub in site 1 is indicated by spheres. The side chains of the catalytic triad are shown in cyan. The
side chains of the cross-linking lysines are also shown explicitly. B) Comparison of the Josephin/K48-linked diUb model and the known structures of
polyUb chains in isolation and in a complex. Top line: the structures of diUb from Ub2 (1aar in cyan, 2bgf in red) and from Ub4 chains (2o6v in green,
1tbe in magenta). Bottom line: the structure diUb from a different crystal form (1f9j in purple); the structure of the UBA domain in complex with Ub2
(1zo6 in gold) and the structure of the Josephin complex (2jri, in blue). Residues L8, I44 and V71, which are often involved in Ub interfaces, are
indicated by green spheres to provide a direct comparison of the relative orientations of the two subunits. With the sole exception of 1f9j, which was
suggested to provide evidence of an open-to-closed equilibrium, the Ub subunits are in a closed conformation when not in a complex. In the two
complexes, the conformation is open with the linkers differently stretched to adapt to the binding sites.
doi:10.1371/journal.pone.0012430.g005
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correct positioning of the Ub C-terminus into the active site as
observed in our models. In contrast, when site 2 is mutated we
observe only modest differences in the cleaving pattern of
Josephin. Site 2 thus seems to be comparably less important and
disposable for cleavage.
These observations suggest two different hypotheses to explain the
role of site 2. According to the first one, site 2 would modulate the
properties of site 1 but would be significantly populated only in full-
length ataxin-3, where correct positioning of polyUb chains would be
determined by the UIMs. It has been shown experimentally that the
two isolated, contiguous ataxin-3 UIMs, which are connected by a
Figure 6. hHR23A influences cleavage of polyUb chains by the Josephin domain.  A))))) Full length ataxin-3 (ataxin-3(Q22); 100 nM) was
incubated with K63-Ub5 (250 nM) chains and either full length GST-tagged hHR23A (100–250 nM) or its GST-tagged UBL domain (100–250 nM).
Fractions were collected at the indicated times. B) Isolated Josephin domain (ataxin-3(1-182); 100 nM) was incubated with K48-Ub5 chains (250 nM)
and either GST-tagged hHR23A (100–250 nM) or its GST-tagged UBL domain (100–250 nM). Samples were collected at the indicated times. Block
arrows highlight differences in cleavage activity among samples. C) Full length ataxin-3 (ataxin-3Q22(WT); 100 nM) or the isolated Josephin domain
(ataxin-3(1-182); 100 nM) were incubated with mixed-linkage polyUb chains (K48-K63-K18-Ub4; 250 nM) and either full-length GST-hHR23A (100–
250 nM) or its GST-tagged UBL domain (100–250 nM). Block arrows highlight differences in cleavage among samples.
doi:10.1371/journal.pone.0012430.g006
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constants around 100 mM and no obvious linkage preferences [16].
Their role couldbecome dominant in full-length ataxin-3, where they
are likelyto provide cooperativity and anchor the polyUb chains. The
unstructured C-terminus, in which all three UIMs reside, would
easily act as a flexible tethering arm which brings the anchored Ub
chains to the catalytic site to be positioned correctly. The UIMs could
also play a determinant role in chain specificity since full-length
ataxin-3 preferentially cleaves K63-linked polyUb [14] whereas we
have demonstrated here that the Josephin domain alone preferen-
tially cleaves K48-linked polyUb (Fig. 3). This model is further
supported by the evidence that mutating the UIMs enhances the
ability of ataxin-3 to cleave K48-linked polyUb chains [14].
A different and more drastic hypothesis is that site 2 is never
populated by Ub but rather by the Ubl of hHR23A and hHR23B
or Ub-like domains in other proteins. Consistent with this, we do
not see significant effects on cleavage when site 2 is saturated with
hHR23A Ubl. This is also in agreement with the tighter affinity of
Josephin with the highly homologous Ubl of hHR23B (12 mM) as
compared with the Kd of ,50 mM for the complex with monoUb
[17]. The presence of other domains of the hHR23 proteins would
also contribute to increase the binding affinity of this protein for
ataxin-3. This possibility has important consequences regarding
our understanding the functions of ataxin-3, particularly in a
cellular context. A complete understanding of ataxin-39s interac-
tions with polyUb awaits, at this point, a structural characteriza-
tion of full-length ataxin-3 in complex with Ub chains. The
unstructured C-terminal portion of ataxin-3 currently presents a
formidable challenge for such studies.
Finally, we observed that, as for full-length ataxin-3 [14], the
isolated Josephin domain prefers to cleave longer polyUb chains.
The pattern of products generated by cleavage of polyUb chains
indicates that terminal Ub-Ub linkages are cleaved more easily
than internal ones. It is uncertain how this occurs at the molecular
level, but this observation suggests that the Josephin domain may
distinguish terminal vs. internal Ub-Ub linkages either as a single
molecule or by interacting with other Josephin domains.
In summary, we have shown that the catalytic domain of the
deubiquitinating enzyme and polyQ disease protein, ataxin-3, has
a preference for interacting with K48-linked diUb chains
compared to K63-linked diUb chains. Ub-binding site 1 on the
Josephin domain is indispensible for the enzymatic activity of
ataxin-3, while site 2 may be dedicated to the recognition of
hHR23 proteins. Our data provide significant new insights into
ataxin-39s interactions with its substrates and the manner in which
isopeptide bonds are positioned for cleavage.
Experimental procedures
Site-directed mutagenesis
The following primers were used to generate missense
mutations of specific residues of ataxin-3 into alanine (Quick-
change Mutagenesis, Stratagene): 59gccttctggaaatatggatgacagtgg-
ttttttctctgctgcggttataagcaatgccttg (forward) and 59caaggcattgctta-
taaccgcagcagagaaaaaaccactgtcatccatatttccagaaggc (reverse) for the
Iso77-Ala/Glu78-Ala mutant, 59ggttataagcaatgccttgaaagttgcgggtt-
tagaactaatcctg (forward) and 59caggattagttctaaacccgcaactttcaagg-
cattgcttataacc (reverse) for the W98A ataxin-3 mutant. Mutations
of the equivalent Josephin residues into lysines were obtained as
previously described [17–18,35]. We observed similar results in
our enzymatic assays whether these specific residues were mutated
to lysine or to alanine. The primers: 59actatccatggagtccatcttccac-
gagaaacaagaaggctcacttgctgctcaacattg (forward) and 59atcttgcgg-
ccgcttacctaatcatctgcaggagttggtcagcttcgcaatctggcagatcacc (reverse)
were used for a C14A Josephin mutant (cloned using NcoI and
NotI restriction sites).
Protein production
The proteins were expressed in E. coli BL21(DE3) and purified
as previously described [35]. Labeled proteins were obtained by
growing E. coli in synthetic medium containing
15NH4Cl as the
sole source of nitrogen. The K48-linked diUb used for structural
studies was produced as described elsewhere [36]. Briefly,
recombinant Ub mutants (UbD77 and UbK48C) were produced
and incubated overnight with E1 (Boston Biochem), Cdc34, ATP,
phosphocreatine, creatine phosphokinase and inorganic pyrophos-
phate at 37uC. The protein was then purified using a monoS
cation exchange column after stopping the reaction by adding
acetic acid at pH 4.5. K63-linked diUb chains were generated
with the same protocol but using UbD77 and UbK63R mutants
and replacing E2 with Ubc13 and Uev1a enzymes. The purity and
chemical identity of the resulting proteins were examined by SDS
polyacrylamide gel electrophoresis and mass spectrometry.
Enzymatic assays
PolyUb chains (250–1000 nM; Boston Biochem) were incubat-
ed with full-length ataxin-3 or isolated Josephin domain species
(100–400 nM) in DUB buffer (50 mM HEPES, 0.5 mM EDTA,
1 mM DTT, 0.1 mg/ml ovalbumin, pH 7.5) at 37uC. Fractions
were collected in 2% SDS, 100 mM DTT sample buffer, boiled
for 1 min and electrophoresed in 15% SDS-PAGE gels or in 4%–
20% Ready Gels (BioRad). SDS-PAGE electrophoresis and
western blotting were conducted as previously described [14,37].
In-gel protein staining by Sypro Ruby (Invitrogen) was conducted
per the manufacturer’s instructions, and imaged in a VersaDoc
MP5000 imager (BioRad) with UV trans-illumination. Rabbit
anti-Ub (1:500; DAKO), mouse anti-ataxin-3 (1H9, 1:1000;
generous gift from Yvon Trottier), rabbit anti-MJD (1:20,000)
[38], goat anti-GST (1:20,000) (GE Healthcare) antibodies were
used for protein detection. High molecular weight (HMW)
ubiquitin species observed by western blotting in enzymatic assays
are believed to be multimers of the respective substrates [14].
Although we routinely observe monoUb generated during our
enzymatic assays, monoUb is less readily detected by western
blotting techniques than longer Ub chains. Thus, for diUb
cleavage assays, to ascertain that diUb is indeed not a substrate for
ataxin-3 we used a combination of western blotting and in-gel
protein detection (as described above), as well as positive controls
with the unrelated DUB USP28 with which the monoUb reaction
product is easily detected. This approach, together with data from
cleavage of polyUb chains by ataxin-3 (in which we detect
monoUb) ensures us that the absence of monoUb from diUb
cleavage assays is due to the actual absence of monoUb generated
during the reaction rather than to a lack of detection on
immunoblots.
Western blotting quantification and statistical analyses
For semi-quantification of western blots, images were collected
below-saturation levels using VersaDoc 5000MP (BioRad).
Quantification was conducted with Quantity One (BioRad).
Background was subtracted equally among all lanes and the
intensity of each band was integrated as the area under each
intensity curve. The sum of intensities of all product bands was
divided by the sum of intensities of all bands in that lane. For
example, for cleavage of Ub5 chains, the equation was: S(IUb4,
IUb3,I Ub2,I Ub1)/S(IUb5,I Ub4,I Ub3,I Ub2,I Ub1). Statistical analyses
of data collected from independent experiments were conducted
The Enzymology of Ataxin-3
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Structure calculations
For structure calculation purposes the biomolecular docking
program, HADDOCK [20,21] was used based on CSP data
analyzsed with a recently developed method, SAMPLEX [39].
SAMPLEX identifies the residues that reflect significant chemical
shift changes through an unbiased and automated methodology; it
outputs three types of residues: residues classified as unaffected
(core family), interfacial (interface family) and intermediate.
SAMPLEX was run to determine the significant changes in the
CSP data of the two binding sites obtained from NMR titrations of
Josephin constructs with a mutation at either site 1 (I77K-Q78K)
or site 2 (W87K). The active residues for docking were defined
based on the SAMPLEX selection (including the intermediate
class for Josephin to increase the possible interface region). For
Josephin, the solvent accessible neighbors of the active residues
within a 10 A ˚ cut-off were selected as passive residues in order to
increase the ambiguity, resulting thus in a larger interface
coverage. Passive residues on the Ub surface were defined in the
same manner using a 5 A ˚ cut-off.
Three different three-body (two Ub molecules and Josephin)
docking runs were performed to test the ability of K48 and K63
linked diUb to interact with Josephin: K48 or K63 linkages were
imposed in two of them. In a third run, ambiguous linkage
restraints were imposed to both K48 and K63 to see which one
would be preferentially selected during docking. In all three runs,
5000 rigid-body docking solutions were generated and the best 200
were subjected to semi-flexible refinement in torsion angle space
followed by refinement in explicit water. Random removal of
restraints was turned off (noecv=false) and additional center-of-
mass restraints were defined between the various molecules to
ensure compact solutions. All other parameters were left to their
HADDOCK default values. The C-terminal tail of each Ub was
defined as fully flexible together with K48 and/or K63 depending
on the linkage type.
The isopeptide bond between the two Ubs was defined by
imposing a loose distance restraint (10 A ˚) between the side chain
ammonium group of either K48 or K63 and the carboxyl atom of
G76. In a third docking run with an ambiguous linkage definition,
an ambiguous distance restraint was defined including both K48
and K63. A final additional water refinement was performed in
which the distance restraint was decreased to 1.5 A ˚ in order to re-
establish the iso-peptide bond.
To check if positioning of Ub into the catalytic site could be
consistent with the measured chemical shift data, the three runs
were repeated with one additional distance restraint (10 A ˚)
between the Josephin side chain sulphur of C14 and the C-
terminal carbon of site 2. This distance was shortened to 5 A ˚ for
the additional water refinement step.
The resulting models of each docking run were clustered with a
5A ˚ cut-off and the clusters ranked based on the average
HADDOCK score calculated over the best four members of each
cluster.
Estimate of the complex stoichiometries
NMR experiments were performed at 298 K on a Bruker
Avance spectrometer operating at 600 MHz and equipped with
cryoprobe. Titrations of
15N labelled Josephin or C14A Josephin
mutant (0.05 mM in 20 mM sodium phosphate pH 6.5, 2 mM
DTT) with diUB chains were performed with stepwise additions of
concentrated stock solutions of K48-linked or K63-linked diUb
chains (1.47 mM and 0.4 mM, respectively) up to a 10 and 2.5
fold molar excess, respectively. Combined measurements of T1
and T2 relaxation times were performed to estimate the
correlation times using a home modified Bruker sequence
(hsqct2etf3gpsi3d). Overall correlation time values were estimated
from the R2/R1 ratio using the program R2R1_TM available
from the website of A.G. Palmer’s group (A.G. Palmer III,
Columbia University) [40]. The values were compared to a
literature calibration curve [41].
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